Artificial Intelligence in COVID-19 Ultrastructure. 2020

Mohamed Y Elwazir, and Somaya Hosny
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Artificial intelligence has found its way into numerous fields of medicine in the past decade, spurred by the availability of big data and powerful processors. For the COVID-19 pandemic, aside from predicting its onset, artificial intelligence has been used to track disease spread, detect pulmonary involvement in computed tomography scans, risk-stratify patients, and model virtual protein structure and potential therapeutic agents. This mini-review briefly discusses the potential applications of artificial intelligence in COVID-19 microscopy.

UI MeSH Term Description Entries

Related Publications

Mohamed Y Elwazir, and Somaya Hosny
January 2022, Methods in molecular biology (Clifton, N.J.),
Mohamed Y Elwazir, and Somaya Hosny
January 2023, Current drug safety,
Mohamed Y Elwazir, and Somaya Hosny
December 2020, The Lancet. Digital health,
Mohamed Y Elwazir, and Somaya Hosny
October 2020, Journal of medical Internet research,
Mohamed Y Elwazir, and Somaya Hosny
October 2023, European review for medical and pharmacological sciences,
Mohamed Y Elwazir, and Somaya Hosny
February 2021, Clinical genitourinary cancer,
Mohamed Y Elwazir, and Somaya Hosny
December 2021, Atencion primaria,
Mohamed Y Elwazir, and Somaya Hosny
December 2021, Sensors (Basel, Switzerland),
Mohamed Y Elwazir, and Somaya Hosny
January 2020, Diabetes & metabolic syndrome,
Mohamed Y Elwazir, and Somaya Hosny
September 2020, Integrative medicine research,
Copied contents to your clipboard!